HIV peripheral neuropathy

Handbook of Clinical Neurology

Volumn 115, Issue , 2013, Pages 515-529

  Gabbai, Alberto Alain ^a   Castelo, Adauto ^a   Oliveira, Acary Souza Bulle ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; HIV; HIV infection; Immune reconstitution inflammatory syndrome; Opportunistic infections; Peripheral nerve diseases

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; OPPORTUNISTIC INFECTION; PERIPHERAL NERVE DISEASES; PERIPHERAL NEUROPATHY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; HIV; HIV INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; OPPORTUNISTIC INFECTIONS; PERIPHERAL NERVE DISEASES;

HIV INFECTIONS; HUMANS; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 84881516934     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52902-2.00029-1     Document Type: Chapter

References (157)

1. Abrams D.I., Jay C.A., Shade S.B., et al. Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial. Neurology 2007, 68:515-521.
2. Agah R., Sockell M., Felsovayni A. Diffuse infiltrative lymphocytosis syndrome in a patient not infected with the human immunodeficiency virus. West J Med 1996, 164:266-268.
3. Almeida V., Mestre T., De Carvalho M. Pseudobulbar syndrome in two patients with human immunodeficiency virus infection. Amyotroph Lateral Scler 2010, 11:220-222.
4. Ances B.M., Vaida F., Rosario D., et al. Role of metabolic syndrome components in HIV-associated sensory neuropathy. AIDS 2009, 23:2317-2322.
5. Anders H.J., Weiss N., Bogner J.R., et al. Ganciclovir and foscarnet efficacy in AIDS-related CMV polyradiculopathy. J Infect 1998, 36:29-33.
6. Arranz Caso J.A., Martinez R., Cabrera F., et al. Miller Fisher syndrome in a patient with HIV infection. AIDS 1997, 11:550-551.
7. Asensio O., Caso J.A., Rojas R. Carpal tunnel syndrome in HIV patients?. AIDS 2002, 16:948-950.
8. Atroshi I., Gummesson C., Johnsson R., et al. Prevalence of carpal tunnel syndrome in a general population. JAMA 1999, 282:153-158.
9. Bassetti B.R., Tres E.S., Ciriaco J.G., et al. Chronic inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alpha 2b in a patient with HIV/HCV coinfection: case report. Rev Soc Bras Med Trop 2010, 43:89-91.
10. Baum M.K., Rafie C., Lai S., et al. Alcohol use accelerates HIV disease progression. AIDS Res Hum Retroviruses 2010, 26:511-518.
11. Beishuizen S.J., Geerlings S.E. Immune reconstitution inflammatory syndrome: immunopathogenesis, risk factors, diagnosis, treatment and prevention. Neth J Med 2009, 67:327-331.
12. Ben M'barek L., Fardet L., Mebazaa A., et al. A retrospective analysis of thalidomide therapy in non-HIV-related Kaposi's sarcoma. Dermatology 2007, 215:202-205.
13. Berger J.R. Spinal cord syphilis associated with human immunodeficiency virus infection: a treatable myelopathy. Am J Med 1992, 92:101-103.
14. Berger J.R., Simpson D.M. The pathogenesis of diffuse infiltrative lymphocytosis syndrome: an AIDS-related peripheral neuropathy. Neurology 1998, 50:855-857.
15. Berger A.R., Schaumburg H.H., Gourevitch M.N., et al. Prevalence of peripheral neuropathy in injection drug users. Neurology 1999, 53:592-597.
16. Berger J.R., Espinosa P.S., Kissel J. Brachial amyotrophic diplegia in a patient with human immunodeficiency virus infection: widening the spectrum of motor neuron diseases occurring with the human immunodeficiency virus. Arch Neurol 2005, 62:817-823.
17. Bhatti M.T., Schmalfuss I.M., Eskin T.A. Isolated cranial nerve III palsy as the presenting manifestation of HIV-related large B-cell lymphoma: clinical, radiological and postmortem observations: report of a case and review of the literature. Surv Ophthalmol 2005, 50:598-606.
18. Bozzette S.A., Santangelo J., Villasana D., et al. Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicity. J Acquir Immune Defic Syndr 1991, 4:851-855.
19. Bradley W.G. Neurology in Clinical Practice 2008, Butterworth-Heinemann/Elsevier, Philadelphia, PA, 2 Vols. 5th edn.
20. Bradley W.G., Verma A. Painful vasculitic neuropathy in HIV-1 infection: relief of pain with prednisone therapy. Neurology 1996, 47:1446-1451.
21. Brannagan T.H., Zhou Y. HIV-associated Guillain-Barre syndrome. J Neurol Sci 2003, 208:39-42.
22. Breen R.A., Lipman M.C., Johnson M.A. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. AIDS 2000, 14:615.
23. Buchacz K., Baker R.K., Palella F.J., et al. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study. AIDS 2010, 24:1549-1559.
24. Burns T.M., Mauermann M.L. The evaluation of polyneuropathies. Neurology 2011, 76:S6-S13.
25. Cacoub P., Saadoun D., Limal N., et al. Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS 2005, 19:S128-S134.
26. Calore E.E., Shulte G., Penalva De Oliveira A.C., et al. Nerve biopsy in patients with AIDS. Pathologica 1998, 90:31-35.
27. Calza L., Manfredi R., Marinacci G., et al. Role of gancyclovir and HAART administration in the treatment of a rare complication of HIV disease: cytomegalovirus-associated Guillain-Barre syndrome. J Chemother 2001, 13:575-577.
28. Canter J.A., Haas D.W., Kallianpur A.R., et al. The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics J 2008, 8:71-77.
29. Canter J.A., Robbins G.K., Selph D., et al. African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapy. J Infect Dis 2010, 201:1703-1707.
30. Capers K.N., Turnacioglu S., Leshner R.T., et al. Antiretroviral therapy-associated acute motor and sensory axonal neuropathy. Case Rep Neurol 2011, 3:1-6.
31. Casanova-Sotolongo P., Casanova-Carrillo P. Association of peripheral facial paralysis in patients with human immunodeficiency virus infection. Rev Neurol 2001, 32:327-330.
32. Castro L., Goldani L.Z. Iron, folate and vitamin B12 parameters in HIV-1 infected patients with anaemia in southern Brazil. Trop Doct 2009, 39:83-85.
33. Castro K., Ward J., Slutsker L., et al. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR 1992, 41. December 18.
34. Centers for Disease Control and Prevention Subpopulation estimates from the HIV incidence surveillance system-United States, 2006. MMWR 2008, 57:985-989.
35. Cepeda J.A., Wilks D. Excess peripheral neuropathy in patients treated with hydroxyurea plus didanosine and stavudine for HIV infection. AIDS 2000, 14:332-333.
36. Chahin N., Temesgen Z., Kurtin P.J., et al. HIV lumbosacral radiculoplexus neuropathy mimicking lymphoma: diffuse infiltrative lymphocytosis syndrome (DILS) restricted to nerve?. Muscle Nerve 2010, 41:276-282.
37. Chaunu M.P., Ratinahirana H., Raphael M., et al. The spectrum of changes on 20 nerve biopsies in patients with HIV infection. Muscle Nerve 1989, 12:452-459.
38. Cherry C.L., Affandi J.S., Brew B.J., et al. Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV. Neurology 2010, 74:1538-1542.
39. Chetty R. Vasculitides associated with HIV infection. J Clin Pathol 2001, 54:275-278.
40. Chimowitz M.I., Audet A.M., Hallet A., et al. HIV-associated CIDP. Muscle Nerve 1989, 12:695-696.
41. Clifford D.B., Smurzynski M., Park L.S., et al. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology 2009, 73:309-314.
42. Cohen J.A., Laudenslager M. Autonomic nervous system involvement in patients with human immunodeficiency virus infection. Neurology 1989, 39:1111-1112.
43. Cohen J.A., Miller L., Polish L. Orthostatic hypotension in human immunodeficiency virus infection may be the result of generalized autonomic nervous system dysfunction. J Acquir Immune Defic Syndr 1991, 4:31-33.
44. Compostella C., Compostella L., D'Elia R. The symptoms of autonomic dysfunction in HIV-positive Africans. Clin Auton Res 2008, 18:6-12.
45. Cornblath D.R., McArthur J.C., Kennedy P.G., et al. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection. Ann Neurol 1987, 21:32-40.
46. de la Monte S.M., Gabuzda D.H., Ho D.D., et al. Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1988, 23:485-492.
47. Deps P.D., Lockwood D.N. Leprosy occurring as immune reconstitution syndrome. Trans R Soc Trop Med Hyg 2008, 102:966-968.
48. Diaz-Villoslada P., Lozano M., Nos C., et al. Syphilitic meningoradiculitis in a patient with HIV. Neurologia 1994, 9:253-255.
49. Dromer F., Moulignier A., Dupont B., et al. Myeloradiculitis due to Cryptococcus curvatus in AIDS. AIDS 1995, 9:395-396.
50. Ellis R.J., Rosario D., Clifford D.B., et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol 2010, 67:552-558.
51. Elston J.W., Thaker H. Immune reconstitution inflammatory syndrome. Int J STD AIDS 2009, 20:221-224.
52. Evans S.R., Ellis R.J., Chen H., et al. Peripheral Neuropathy in HIV: prevalence and risk factors. AIDS 2011, 25:919-928.
53. Evans D., Takuva S., Rassool M., et al. Prevalence of peripheral neuropathy in antiretroviral therapy naive HIV-positive patients and the impact on treatment outcomes: a retrospective study from a large urban cohort in Johannesburg, South Africa. J Neurovirol 2012, 18:162-171.
54. Evans S.R., Lee A.J., Ellis R.J., et al. HIV peripheral neuropathy progression: protection with glucose-lowering drugs?. J Neurovirol 2012, 18:428-433.
55. Ferrari S., Vento S., Monaco S., et al. Human immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc 2006, 81:213-219.
56. Freeman R., Roberts M.S., Friedman L.S., et al. Autonomic function and human immunodeficiency virus infection. Neurology 1990, 40:575-580.
57. Fuller G.N., Jacobs J.M., Guiloff R.J. Subclinical peripheral nerve involvement in AIDS: an electrophysiological and pathological study. J Neurol Neurosurg Psychiatry 1991, 54:318-324.
58. Fuller G.N., Jacobs J.M., Guiloff R.J. Nature and incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg Psychiatry 1993, 56:372-381.
59. Gabbai A.A., Schmidt B., Castelo A., et al. Muscle biopsy in AIDS and ARC: analysis of 50 patients. Muscle Nerve 1990, 13:541-544.
60. Gherardi R.K., Chretien F., Delfau-Larue M.H., et al. Neuropathy in diffuse infiltrative lymphocytosis syndrome: an HIV neuropathy, not a lymphoma. Neurology 1998, 50:1041-1044.
61. Gluck T., Degenhardt E., Scholmerich J., et al. Autonomic neuropathy in patients with HIV: course, impact of disease stage, and medication. Clin Auton Res 2000, 10:17-22.
62. Gompels M.M., Hill A., Jenkins P., et al. Kaposi's sarcoma in HIV infection treated with vincristine and bleomycin. AIDS 1992, 6:1175-1180.
63. Gorson K.C., van Schaik I.N., Merkies I.S., et al. Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice. J Peripher Nerv Syst 2010, 15:326-333.
64. Grafe M.R., Wiley C.A. Spinal cord and peripheral nerve pathology in AIDS: the roles of cytomegalovirus and human immunodeficiency virus. Ann Neurol 1989, 25:561-566.
65. Guillevin L. Vasculitides in the context of HIV infection. AIDS 2008, 22:S27-S33.
66. Gulevich S.J., Kalmijn J.A., Thal L.J., et al. Sensory testing in human immunodeficiency virus type 1-infected men. HIV Neurobehavioral Research Center Group. Arch Neurol 1992, 49:1281-1284.
67. Hagberg L., Malmvall B.E., Svennerholm L., et al. Guillain-Barre syndrome as an early manifestation of HIV central nervous system infection. Scand J Infect Dis 1986, 18:591-592.
68. Hall C.D., Snyder C.R., Messenheimer J.A., et al. Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients: incidence and relationship to other nervous system dysfunction. Arch Neurol 1991, 48:1273-1274.
69. Harrison L.H., Vaz B., Taveira D.M., et al. Myelopathy among Brazilians coinfected with human T-cell lymphotropic virus type I and HIV. Neurology 1997, 48:13-18.
70. Hart A.M., Wilson A.D., Montovani C., et al. Acetyl-l-carnitine: a pathogenesis based treatment for HIV-associated antiretroviral toxic neuropathy. AIDS 2004, 18:1549-1560.
71. Hepburn M.J., Dyal K., Runser L.A., et al. Low serum vitamin B12 levels in an outpatient HIV-infected population. Int J STD AIDS 2004, 15:127-133.
72. Hiraga A., Kuwabara S., Nakamura A., et al. Fisher/Gullain-Barre overlap syndrome in advanced AIDS. J Neurol Sci 2007, 258:148-150.
73. Hirsch H.H., Kaufmann G., Sendi P., et al. Immune reconstitution in HIV-infected patients. Clin Infect Dis 2004, 38:1159-1166.
74. Ho D.D., Rota T.R., Schooley R.T., et al. Isolation of HTLV-III from cerebrospinal fluid and neural tissues of patients with neurologic syndromes related to the acquired immunodeficiency syndrome. N Engl J Med 1985, 313:1493-1497.
75. Hoffman P.M., Festoff B.W., Giron L.T., et al. Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N Engl J Med 1985, 313:324-325.
76. Hoschele D. Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity. Toxicol In Vitro 2006, 20:535-546.
77. Hughes R.A., Cornblath D.R. Guillain-Barre syndrome. Lancet 2005, 366:1653-1666.
78. Hung C.C., Hsiao C.F., Wang J.L., et al. Herpes zoster in HIV-1-infected patients in the era of highly active antiretroviral therapy: a prospective observational study. Int J STD AIDS 2005, 16:673-676.
79. Jacomet C., Lebrette M.G., el Amrani M., et al. Lesions of the conus medullaris and the cauda equina caused by cytomegalovirus in HIV infection: 7 cases. Presse Med 1995, 24:527-530.
80. Jongwutiwes U., Malathum K., Sungkanuparph S. Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy. J Med Assoc Thai 2007, 90:85-88.
81. Juul T., Malolepszy A., Dybkaer K., et al. The in vivo toxicity of hydroxyurea depends on its direct target catalase. J Biol Chem 2010, 285:21411-21415.
82. Kallianpur A.R., Hulgan T. Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathy. Pharmacogenomics 2009, 10:623-637.
83. Kallianpur A.R., Hulgan T., Canter J.A., et al. Hemochromatosis (HFE) gene mutations and peripheral neuropathy during antiretroviral therapy. AIDS 2006, 20:1503-1513.
84. Keswani S.C., Pardo C.A., Cherry C.L., et al. HIV-associated sensory neuropathies. AIDS 2002, 16:2105-2117.
85. Kieburtz K.D., Giang D.W., Schiffer R.B., et al. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Association with neurological dysfunction. Arch Neurol 1991, 48:312-314.
86. Kieburtz K., Simpson D., Yiannoutsos C., et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology 1998, 51:1682-1688.
87. Kim Y.J., Fan Y., Laurie P., et al. No evidence of HIV pol gene in spinal cord tissues in sporadic ALS by real-time RT-PCR. Amyotroph Lateral Scler 2010, 11:91-96.
88. La Spina I., Porazzi D., Maggiolo F., et al. Gabapentin in painful HIV-related neuropathy: a report of 19 patients, preliminary observations. Eur J Neurol 2001, 8:71-75.
89. Lanska M.J., Lanska D.J., Schmidley J.W. Syphilitic polyradiculopathy in an HIV-positive man. Neurology 1988, 38:1297-1301.
90. Le Lostec Z., Fegueux S., Vitale C., et al. Peripheral neuropathy associated with cryoglobulinaemia but not related to hepatitis C virus in an HIV-infected patient. AIDS 1994, 8:1351-1352.
91. Lee K., Vivithanaporn P., Siemieniuk R.A., et al. Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS. BMC Neurol 2010, 10:44.
92. Leger J.M., Bouche P., Bolgert F., et al. The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatry 1989, 52:1369-1374.
93. Leger J.M., Henin D., Belec L., et al. Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol 1992, 239:132-134.
94. Lehmann H.C., Chen W., Borzan J., et al. Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathy. Ann Neurol 2010, 69:100-110.
95. Lenhard T., Biller A., Mueller W., et al. Immune reconstitution inflammatory syndrome after withdrawal of natalizumab?. Neurology 2010, 75:831-833.
96. Levy J.A., Shimabukuro J., Hollander H., et al. Isolation of AIDS-associated retroviruses from cerebrospinal fluid and brain of patients with neurological symptoms. Lancet 1985, 2:586-588.
97. Lewin S.R., Evans V.A., Elliott J.H., et al. Finding a cure for HIV: will it ever be achievable?. J Int AIDS Soc 2011, 14:4.
98. Lichtenstein K.A., Armon C., Baron A., et al. Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis 2005, 40:148-157.
99. Lima A.L., Zumiotti A.V., Camanho G.L., et al. Osteoarticular complications related to HIV infection and highly active antiretroviral therapy. Braz J Infect Dis 2007, 11:426-429.
100. Lockwood D.N., Lambert S.M. Human immunodeficiency virus and leprosy: an update. Dermatol Clin 2011, 29:125-128.
101. Makela P., Howe L., Glover S., et al. Recurrent Guillain-Barre syndrome as a complication of immune reconstitution in HIV. J Infect 2002, 44:47-49.
102. Manfredi R., Calza L., Chiodo F. Carpal tunnel syndrome in HIV-infected patients treated with highly active antiretroviral therapy: other case reports. Rheumatol Int 2001, 21:81-83.
103. Marais S., Wilkinson R.J., Pepper D.J., et al. Management of patients with the immune reconstitution inflammatory syndrome. Curr HIV/AIDS Rep 2009, 6:162-171.
104. Marcus K., Truffa M., Boxwell D., et al. Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Recently identified adverse events secondary to NRTI therapy in HIV-infected individuals: cases from the FDA's adverse event reporting system (AERS) [abstract LB14] 2002, Foundation for Retrovirology and Human Health, Alexandria, VA, Available at. http://retroconference.org/2002/Abstract/14036.htm.
105. Maritz J., Benatar M., Dave J.A., et al. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve 2010, 41:599-606.
106. Marra C.M., Boutin P., Collier A.C. Screening for distal sensory peripheral neuropathy in HIV-infected persons in research and clinical settings. Neurology 1998, 51:1678-1681.
107. Martin-Blondel G., Delobel P., Blancher A., et al. Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain 2011, 134:928-946.
108. McArthur J.C., Griffin J.W., Cornblath D.R. Steroid-responsive myeloneuropathy in a man dually infected with HIV-1 and HTLV-I. Neurology 1990, 40:938-944.
109. McArthur J.C., Yiannoutsos C., Simpson D.M., et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. AIDS Clinical Trials Group Team 291. Neurology 2000, 54:1080-1088.
110. McCarty M. How clinically relevant is dapsone-related peripheral neuropathy? An overview of available data with emphasis on clinical recognition. J Clin Aesthet Dermatol 2010, 3:19-21.
111. McCarthy M., Nath A. Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS). Curr Neurol Neurosci Rep 2010, 10:467-475.
112. McCarthy W.F., Gable J., Lawrence J., et al. A retrospective study to determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals. Pharmacoepidemiol Drug Saf 2000, 9:49-53.
113. Mellion M., Gilchrist J.M., De La Monte S. Alcohol-related peripheral neuropathy: nutritional, toxic, or both?. Muscle Nerve 2011, 43:309-316.
114. Miller R.F., Fox J.D., Thomas P., et al. Acute lumbosacral polyradiculopathy due to cytomegalovirus in advanced HIV disease: CSF findings in 17 patients. J Neurol Neurosurg Psychiatry 1996, 61:456-460.
115. Miller R.F., Bunting S., Sadiq S.T., et al. Peripheral neuropathy in patients with HIV infection: consider dual pathology. Sex Transm Infect 2002, 78:462-463.
116. Morgello S., Estanislao L., Simpson D., et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol 2004, 61:546-551.
117. Moulignier A., Authier F.J., Baudrimont M., et al. Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome. Ann Neurol 1997, 41:438-445.
118. Moura L., Oliveira A.S., Zanoteli E., et al. Normal pattern of intraepidermal nerve fibers in 30 healthy volunteers with PGP 9.5. Arq Neuropsiquiatr 2004, 62:271-275.
119. Muller M., Wandel S., Colebunders R., et al. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010, 10:251-261.
120. Nachega J.B., Trotta M.P., Nelson M., et al. Impact of metabolic complications on antiretroviral treatment adherence: clinical and public health implications. Curr HIV/AIDS Rep 2009, 6:121-129.
121. Nalini A., Desai A., Mahato S.K. Flail arm-like syndrome associated with HIV-1 infection. Ann Indian Acad Neurol 2009, 12:127-130.
122. Ooi W.W., Srinivasan J. Leprosy and the peripheral nervous system: basic and clinical aspects. Muscle Nerve 2004, 30:393-409.
123. Othieno-Abinya N.A., Nyabola L.O. Experience with vincristine-associated neurotoxicity. East Afr Med J 2001, 78:376-378.
124. Parry G.J. Peripheral neuropathies associated with human immunodeficiency virus infection. Ann Neurol 1988, 23:S49-S53.
125. Pavie J., De Castro N., Molina J.M., et al. Severe peripheral neuropathy following HAART initiation in an HIV-infected patient with leprosy. J Int Assoc Physicians AIDS Care 2010, 9:232-235.
126. Pfeffer G., Cote H.C., Montaner J.S., et al. Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy. Neurology 2009, 73:71-72.
127. Phillips T.J., Cherry C.L., Cox S., et al. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE 2010, 5:e14433.
128. Piliero P.J., Fish D.G., Preston S., et al. Guillain-Barre syndrome associated with immune reconstitution. Clin Infect Dis 2003, 36:e111-e114.
129. Polydefkis M., Yiannoutsos C.T., Cohen B.A., et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002, 58:115-119.
130. Robinson-Papp J., Simpson D.M. Neuromuscular diseases associated with HIV-1 infection. Muscle Nerve 2009, 40:1043-1053.
131. Ronsholt F.F., Ostrowski S.R., Katzenstein T.L., et al. T cell subsets in HIV infected patients after successful combination antiretroviral therapy: impact on survival after 12 years. PLoS ONE 2012, 7:e39356.
132. Rutschmann O.T., Vernazza P.L., Bucher H.C., et al. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study. AIDS 2000, 14:2145-2151.
133. Ruttimann S., Hilti P., Spinas G.A., et al. High frequency of human immunodeficiency virus-associated autonomic neuropathy and more severe involvement in advanced stages of human immunodeficiency virus disease. Arch Intern Med 1991, 151:2441-2443.
134. Said G., Lacroix C., Chemouilli P., et al. Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: a clinical and pathological study. Ann Neurol 1991, 29:139-146.
135. Sakhuja A., Goyal A., Jaryal A.K., et al. Heart rate variability and autonomic function tests in HIV positive individuals in India. Clin Auton Res 2007, 17:193-196.
136. Schleicher G.K., Black A., Mochan A., et al. Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barre syndrome. Crit Care Med 2003, 31:1848-1850.
137. Shah S.S., Rodriguez T., McGowan J.P. Miller Fisher variant of Guillain-Barre syndrome associated with lactic acidosis and stavudine therapy. Clin Infect Dis 2003, 36:e131-e133.
138. Sillevis Smitt P.A., Portegies P. Fisher's syndrome associated with human immunodeficiency virus infection. Clin Neurol Neurosurg 1990, 92:353-355.
139. Simpson D.M., Kitch D., Evans S.R., et al. HIV neuropathy natural history cohort study: assessment measures and risk factors. Neurology 2006, 66:1679-1687.
140. Simpson D.M., Schifitto G., Clifford D.B., et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology 2010, 74:413-420.
141. Sithinamsuwan P., Punthanamongkol S., Valcour V., et al. Frequency and characteristics of HIV-associated sensory neuropathy among HIV patients in Bangkok, Thailand. J Acquir Immune Defic Syndr 2008, 49:456-458.
142. Snider W.D., Simpson D.M., Nielsen S., et al. Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 1983, 14:403-418.
143. So Y.T., Olney R.K. Acute lumbosacral polyradiculopathy in acquired immunodeficiency syndrome: experience in 23 patients. Ann Neurol 1994, 35:53-58.
144. Steichen O., Martinez-Almoyna L., De Broucker T. Isoniazid induced neuropathy: consider prevention. Rev Mal Respir 2006, 23:157-160.
145. Steininger C. Novel therapies for cytomegalovirus disease. Recent Pat Antiinfect Drug Discov 2007, 2:53-72.
146. Teo E.C., Azwra A., Jones R.L., et al. Guillain-Barre syndrome following immune reconstitution after antiretroviral therapy for primary HIV infection. J HIV Ther 2007, 12:62-63.
147. Verma A., Berger J.R. ALS syndrome in patients with HIV-1 infection. J Neurol Sci 2006, 240:59-64.
148. Villa A., Foresti V., Confalonieri F. Autonomic nervous system dysfunction associated with HIV infection in intravenous heroin users. AIDS 1992, 6:85-89.
149. Wenzel G.I., Gotz F., Lenarz T., et al. HIV-associated cerebral lymphocyte infiltration mimicking vestibular schwannoma. Eur Arch Otorhinolaryngol 2008, 265:1567-1571.
150. Woolsey R.M., Chambers T.J., Chung H.D., et al. Mycobacterial meningomyelitis associated with human immunodeficiency virus infection. Arch Neurol 1988, 45:691-693.
151. Wooltorton E. HIV drug stavudine (Zerit, d4T) and symptoms mimicking Guillain-Barre syndrome. Can Med Assoc J 2002, 166:1067.
152. Wright E., Brew B., Arayawichanont A., et al. Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 2008, 71:50-56.
153. Wulff E.A., Wang A.K., Simpson D.M. HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000, 59:1251-1260.
154. Yeo J.C., Trotter M.I., Wilson F. Bilateral facial nerve palsy associated with HIV seroconversion illness. Postgrad Med J 2008, 84:328-329.
155. Younger D.S., Rosoklija G., Neinstedt L.J., et al. HIV-1 associated sensory neuropathy: a patient with peripheral nerve vasculitis. Muscle Nerve 1996, 19:1364-1366.
156. Zanetti C., Manzano G.M., Gabbai A.A. The frequency of peripheral neuropathy in a group of HIV positive patients in Brazil. Arq Neuropsiquiatr 2004, 62:253-256.
157. Zhou L., Kitch D.W., Evans S.R., et al. Correlates of epidermal nerve fiber densities in HIV-associated distal sensory polyneuropathy. Neurology 2007, 68:2113-2119.